Definitive Contract HHSD200201034037C
Award Date 4/1/10
Potential Completion Date 3/31/11
Potential Value $39B
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Point, PA 19486, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $29,475,985.60 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the provision of various adult vaccines. The contract has a period of performance from July 1, 2015, to June 30, 2016, and is a firm fixed-price contract. Merck is a large pharmaceutical manufacturer that has been a critical partner in supplying essential vaccines and pharmaceutical products to support federal healthcare...
- This is a $68,321,497.07 definitive contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The contract is for the provision of various vaccines, including MMR, varicella, hepatitis, pneumococcal, tetanus, diphtheria, human papillomavirus, and meningococcal vaccines. This contract is not set aside and is part of Merck's larger portfolio of federal contracts, including indefinite delivery vehicles...
- This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc.'s Wyeth division. The contract, valued at $15,297,409,927.00, is for the Vaccines for Children (VFC) Pediatric Vaccine Contract and has a period of performance ending on March 31, 2010. The contract is a Definitive Contract with a Firm Fixed Price pricing type and does not have a set-aside designation. The contract is for the delivery of pediatric vaccines...
- This is a definitive, firm fixed-price contract awarded by the CDC Office of Acquisition Services, a civilian agency, to Glaxosmithkline Holdings (Americas) Inc. on April 1, 2009. The contract, valued at $13,015,897,209.20, is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has a period of performance through March 31, 2010 and does not have a set-aside designation. As the prime contractor, Glaxosmithkline Holdings (Americas) Inc. will be...
- Merck Sharp & Dohme LLC was awarded a firm fixed price, definite contract valued at $75,294,061.41 by the Department of Health and Human Services Centers for Disease Control and Prevention to provide adult vaccines with performance through June 30, 2018. As the prime contractor, Merck will deliver a range of pharmaceutical products and vaccines from its Whitehouse Station, New Jersey place of performance to support the CDC's immunization programs. No set-aside designation was applied to this...
- This is a definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit organization. The contract, valued at $3,998,636,358.75, is for the TAS 00HCVGBC-2010-82345 - Novartis Pediatric Vaccine Contract and does not have a set-aside designation. The contract has an ultimate completion date of March 31, 2011. As a pediatric vaccine contract, this award...
- This federal contract award, valued at $97,091.53, was issued by the Office of the Assistant Secretary for Administration (a civilian agency) to Merck Sharp & Dohme LLC, doing business as Merck, for the delivery of MERCK VACCINES FOR STOCK. The contract is a Firm Fixed Price Delivery Order without a set-aside designation. Merck is a major pharmaceutical manufacturer and supplier to the U.S. federal government, providing a wide range of vaccines, drugs, and medical countermeasures to...
- This contract award is for Merck Sharp & Dohme LLC, doing business as Merck, to provide vaccines to the U.S. Department of Health and Human Services. The $112,703.00 firm fixed-price delivery order falls under Merck's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract has no set-aside designation. Merck, a for-profit manufacturer, is the prime contractor. The contract supports the Centers for Disease Control and...
- This federal contract award MERCK VACCINES FOR STOCK was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer and supplier. The $88,659.80 firm fixed-price delivery order was placed against Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract does not have a set-aside designation. Merck is a subsidiary of Schering Plough...
- This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of vaccines to the U.S. government. The award, valued at $329,344.00, is a delivery order under Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs. The award supports the government's MERCK VACCINES FOR STOCK requirement and was made by the Office of the Assistant Secretary for Administration, a civilian agency. The contract has a firm fixed price pricing type and does not...